Phase II, Single-Arm, Open-Label, Multicenter Study Evaluating the Efficacy of Adjunctive Zanubrutinib and CAR T-Cell Therapy in Aggressive B-cell Non-Hodgkins Lymphoma

Protocol No
NU-20H09-NHL
Phase
II
Summary

To assess the anticancer effect of zanubrutinib with CAR-T therapy in aggressive lymphoma.

Description
Phase II Study Evaluating Adjunctive Zanubrutinib and CAR T-cell therapy in Aggressive B-cell Non-Hodgkins Lymphoma
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
Cancer, Lymphoma, Hematologic/Blood Related Cancers
ClinicalTrials.gov
go to website